首页> 美国卫生研究院文献>Acta Pharmaceutica Sinica. B >5-Monophosphate-activated protein kinase (AMPK) improves autophagic activity in diabetes and diabetic complications
【2h】

5-Monophosphate-activated protein kinase (AMPK) improves autophagic activity in diabetes and diabetic complications

机译:5-单磷酸激活蛋白激酶(AMPK)改善糖尿病和糖尿病并发症的自噬活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diabetes mellitus (DM), an endocrine disorder, will be one of the leading causes of death world-wide in about two decades. Cellular injuries and disorders of energy metabolism are two key factors in the pathogenesis of diabetes, which also become the important causes for the process of diabetic complications. AMPK is a key enzyme in maintaining metabolic homeostasis and has been implicated in the activation of autophagy in distinct tissues. An increasing number of researchers have confirmed that autophagy is a potential factor to affect or induce diabetes and its complications nowadays, which could remove cytotoxic proteins and dysfunctional organelles. This review will summarize the regulation of autophagy and AMPK in diabetes and its complications, and explore how AMPK stimulates autophagy in different diabetic syndromes. A deeper understanding of the regulation and activity of AMPK in autophagy would enhance its development as a promising therapeutic target for diabetes treatment.
机译:糖尿病(DM)是一种内分泌疾病,将在大约二十年内成为全球范围内主要的死亡原因之一。细胞损伤和能量代谢紊乱是糖尿病发病机理中的两个关键因素,也成为糖尿病并发症发生的重要原因。 AMPK是维持代谢稳态的关键酶,并已参与不同组织中自噬的激活。越来越多的研究人员证实,自噬是当今影响或诱发糖尿病及其并发症的潜在因素,它可以清除细胞毒性蛋白质和功能性细胞器。这篇综述将总结自噬和AMPK在糖尿病及其并发症中的调节作用,并探讨AMPK如何刺激不同糖尿病综合征的自噬。对AMPK在自噬中的调控和活性的更深入了解将增强其作为糖尿病治疗有希望的治疗靶点的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号